Prevalence of human papillomavirus (HPV)-vaccine types by race/ethnicity and sociodemographic factors in women with high-grade cervical intraepithelial neoplasia (CIN2/3/AIS), Alameda County, California, United States
Kayla Saadeh(California Department of Public Health), Michael J. Silverberg(Kaiser Permanente), Troy D. Querec, Ina Park(Pohang University of Science and Technology), Erin Whitney(California Department of Public Health), Leo B. Hurley(Kaiser Permanente), Julia W. Gargano(Canadian Institutes of Health Research)
Cited by 16
Related Papers
Sexually Transmitted Infections Treatment Guidelines, 2021
|MMWR Recommendations and Reports|2021|2.5k
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
|The Lancet|2019|1.3k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016
|JAMA Network Open|2020|614
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602